This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, J.-M.
Right arrow Articles by Fukayama, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, J.-M.
Right arrow Articles by Fukayama, M.

 Previous Article  |  Next Article 

Journal of Virology, July 2002, p. 6825-6831, Vol. 76, No. 13
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.13.6825-6831.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Interleukin-1ß Expression in Human Gastric Carcinoma with Epstein-Barr Virus Infection

Ja-Mun Chong,1* Kazuya Sakuma,2 Makoto Sudo,3 Toshio Osawa,1,3 Etsuko Ohara,1 Hiroshi Uozaki,1 Junji Shibahara,1 Kenji Kuroiwa,4,5 Shin-ichi Tominaga,4 Yoshitaka Hippo,6 Hiroyuki Aburatani,6 Nobuaki Funata,7 and Masashi Fukayama1

Department of Pathology, Graduate School of Medicine,1 Department of Applied Biological Science, Graduate School of Science and Technology,5 Division of Genome Science, Research Center for Advanced Science and Technology, The University of Tokyoand,6 Department of Pathology, Tokyo Metropolitan Komagome Hospital, Tokyo,,7 Department of Surgery,2 Department of Biochemistry, Jichi Medical School,4 Tochigi, and Department of Surgery, Yamanashi Medical UniversityYamanashi,Japan3

Received 5 September 2001/ Accepted 26 March 2002

The KT tumor is a transplantable strain of a human Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC), established in severe combined immunodeficiency (SCID) mice, with which the cytokine expression of EBVaGC can be investigated without interference from the infiltrating lymphocytes. As a part of a high-density oligonucleotide array (GeneChip) analysis of EBVaGC, the interleukin-1ß (IL-1ß) gene was the only cytokine gene that showed markedly higher expression in the KT tumor cells than in two tumor strains of EBV-negative GC. The results were confirmed by Northern blotting, Western blotting, and enzyme-linked immunosorbent assay. Furthermore, we demonstrated a positive signal for IL-1ß mRNA in the carcinoma cells of a surgically resected EBVaGC, but not in EBV-negative GC, by in situ hybridization. In vitro, IL-1ß increased the cell growth of a GC cell line, TMK1. Thus, IL-1ß may act as an autocrine growth factor in EBVaGC.


* Corresponding author. Mailing address: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-5841-3341. Fax: 81-3-3815-8379. E-mail: jmchong-tky{at}umin.ac.jp.


Journal of Virology, July 2002, p. 6825-6831, Vol. 76, No. 13
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.13.6825-6831.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Thiel, A., Ganesan, A., Mrena, J., Junnila, S., Nykanen, A., Hemmes, A., Tai, H.-H., Monni, O., Kokkola, A., Haglund, C., Petrova, T. V., Ristimaki, A. (2009). 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer. Clin. Cancer Res. 15: 4572-4580 [Abstract] [Full Text]  
  • Hino, R., Uozaki, H., Inoue, Y., Shintani, Y., Ushiku, T., Sakatani, T., Takada, K., Fukayama, M. (2008). Survival Advantage of EBV-Associated Gastric Carcinoma: Survivin Up-regulation by Viral Latent Membrane Protein 2A. Cancer Res. 68: 1427-1435 [Abstract] [Full Text]  
  • Diamandis, E. P., Yip, T. T. C., Ngan, R. K. C., Cho, W. C. S., Au, J. S. K., Law, S. C. K., Yip, T.-T. (2004). Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker for Nasopharyngeal Carcinoma. Clin. Cancer Res. 10: 5293-5294 [Full Text]  
  • Yamanaka, N., Morisaki, T., Nakashima, H., Tasaki, A., Kubo, M., Kuga, H., Nakahara, C., Nakamura, K., Noshiro, H., Yao, T., Tsuneyoshi, M., Tanaka, M., Katano, M. (2004). Interleukin 1{beta} Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-{kappa}B Activation. Clin. Cancer Res. 10: 1853-1859 [Abstract] [Full Text]